Targeting of interleukin-2 to human MK-1-expressing carcinoma by fusion with a single-chain Fv of anti-MK-1 antibody

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2001-2007

  Matsumoto, Hisanobu ^a   Liao, Shaoxi ^a   Arakawa, Fumiko ^a   Ueno, Aruto ^a   Abe, Hironori ^a   Awasthi, Aradhana ^a   Kuroki, Motomu ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fusion protein; IL 2; Immunotherapy; MK 1; ScFv

Indexed keywords

ANTIBODY; ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; HYBRID PROTEIN; INTERLEUKIN 2; MK 1 ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CARCINOMA; CHROMATOGRAPHY; CYTOTOXICITY; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PURIFICATION; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD3; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CELL ADHESION MOLECULES; CELL DIVISION; DNA PRIMERS; GENE TARGETING; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; KINETICS; MICE; MICE, SCID; PICHIA; RECOMBINANT FUSION PROTEINS; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036339224     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Cytokines in cancer therapy
2. Progress in human tumour immunology and immunotherapy
3. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer
4. Effects of tumour necrosis factor-alpha (TNF-α), IL-1β and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes
5. Metabolic and renal effects of interleukin-2 immunotherapy for metastatic cancer
6. Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthiourea
7. Antibody- targeted interleukin-2 stimulates T-cell killing of autologous tumor cells
8. Antibody-interleukin 2 fusion proteins: A new approach to cancer therapy
9. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma
10. Molecular identification of a human adenocarcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1
11. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2
12. Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies
13. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies
14. Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells
15. Randomised trial of monoclonal antibody for adjuvant therapy of resected Duke's C colorectal carcinoma
16. Construction, expression and characterization of a single chain anti-tumour antibody (scFv)-IL-2 fusion protein
17. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody
18. Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein
19. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies
20. Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model
21. In vitro tumor targeting of a recombinant single-chain antigen-binding protein
22. Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
23. Protein engineering of Ab binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
24. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines
25. a (dimeric Lea) mediated by monoclonal antibody NCC-ST-421 in adoptive immunization using SCID mice
26. cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction a mouse/human chimeric antibody
27. Single-chain Fv with Fc fragment of the human IgG1 tag: Construction, Pichia pastoris expression and antigen binding characterization
28. Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2
29. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins
30. Single-chain Fv antibodies for targeting cancer therapy
31. Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model
32. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin-2 immunoconjugate